Manufacturer record
Finemax Formulation Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Finemax Formulation Pvt. Ltd (Tamil Nadu) were declared Not of Standard Quality between January 2026 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: FMX-030/26, Ambroxol Hydrochloride, Terbutaline Sulphate, Guiaphenesin & Menthol Syrup (exp Feb 2028). Drugs Testing Laboratory, Chennai-06 (state lab) found it not of standard quality: The sample does not conform to label claim with respect to the content of Ambroxol Hydrochloride and Terbutaline Sulphate. Listed in the July 2026 alert.
Records by type
2 records linked to Finemax Formulation Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guiaphenesin & Menthol Syrup | Batch FMX-030/26Mfg Mar 2026 · Exp Feb 2028 | The sample does not conform to label claim with respect to the content of Ambroxol Hydrochloride and Terbutaline Sulphate.Labelling | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup | Batch PLP-005Mfg Oct 2024 · Exp Sep 2026 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Jan 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.